Hovagim Bakardjian

Hovagim Bakardjian

Auto-generated profile, based on publicly available information

Hovagim Bakardjian

IHU-A-ICM - Paris Institute of Translational Neurosciences, Hopital Pitie-Salpetriere Paris France

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
BDBruno Dubois
Bruno Dubois
HHHarald Hampel
Harald Hampel
HFHoward H. Feldman
Howard H. Feldman
PSPhilip Scheltens
Philip Scheltens
PAPaul Aisen
Paul Aisen
CJCliff R. Jack
Cliff R. Jack

18 June 2019 in Brain
Verified
Journal Article
Closed access
SGSinead Gaubert
Sinead Gaubert
FRFederico Raimondo
Federico Raimondo
MHMarion Houot
Marion Houot
MCMarie-Constance Corsi
Marie-Constance Corsi
LNLionel Naccache
Lionel Naccache
AIAlzheimer’s Disease Neuroimaging Initiative
Alzheimer’s Disease Neuroimaging Initiative
Early biomarkers are needed to identify individuals at high risk of preclinical Alzheimer’s disease and to better understand the pathophysiological processes of disease progression. Preclinical Alzheimer’s disease EEG changes would be non-invasive and cheap screening tools and could also help to predict future progression to clinical Alzheimer’s disease. However, the impact of amyloid-β deposition and neurodegeneration on EEG biomarkers needs to be elucidated. We included participants from the INSIGHT-preAD cohort, which is an ongoing single-centre multimodal observational study that was designed to identify risk factors and markers of progression to clinical Alzheimer’s disease in 318 cognitively normal individuals aged 70–85 years with a subjective memory complaint. We divided the subjects into four groups, according to their amyloid status (based on 18F-florbetapir PET) and neurodegeneration status (evidenced by 18F-fluorodeoxyglucose PET brain metabolism in Alzheimer’s disease signature regions). The first group was amyloid-positive and neurodegeneration-positive, which corresponds to stage 2 of preclinical Alzheimer’s disease. The second group was amyloid-positive and neurodegeneration-negative, which corresponds to stage 1 of preclinical Alzheimer’s disease. The third group was amyloid-negative and neurodegeneration-positive, which corresponds to ‘suspected non-Alzheimer’s pathophysiology’. The last group was the control group, defined by amyloid-negative and neurodegeneration-negative subjects. We analysed 314 baseline 256-channel high-density eyes closed 1-min resting state EEG recordings. EEG biomarkers included spectral measures, algorithmic complexity and functional connectivity assessed with a novel information-theoretic measure, weighted symbolic mutual information. The most prominent effects of neurodegeneration on EEG metrics were localized in frontocentral regions with an increase in high frequency oscillations (higher beta and gamma power) and a decrease in low frequency oscillations (lower delta power), higher spectral entropy, higher complexity and increased functional connectivity measured by weighted symbolic mutual information in theta band. Neurodegeneration was associated with a widespread increase of median spectral frequency. We found a non-linear relationship between amyloid burden and EEG metrics in neurodegeneration-positive subjects, either following a U-shape curve for delta power or an inverted U-shape curve for the other metrics, meaning that EEG patterns are modulated differently depending on the degree of amyloid burden. This finding suggests initial compensatory mechanisms that are overwhelmed for the highest amyloid load. Together, these results indicate that EEG metrics are useful biomarkers for the preclinical stage of Alzheimer’s disease.

1 January 2010 in Neuroscience Letters
Verified
Journal Article
Closed access
HBHovagim Bakardjian
Hovagim Bakardjian
Toshihisa TanakaToshihisa Tanaka
Toshihisa Tanaka
ACAndrzej Cichocki
Andrzej Cichocki

1 April 2014 in Biochemical Pharmacology
Verified
Journal Article
Closed access
HHHarald Hampel
Harald Hampel
SLSimone Lista
Simone Lista
STStefan J. Teipel
Stefan J. Teipel
FGFrancesco Garaci
Francesco Garaci
RNRobert Nistico
Robert Nistico
BDBruno Dubois
Bruno Dubois

10 October 2008 in Computer
Verified
Journal Article
Closed access
ACAndrzej Cichocki
Andrzej Cichocki
YWYoshikazu Washizawa
Yoshikazu Washizawa
Tomasz RutkowskiTomasz Rutkowski
Tomasz Rutkowski
HBHovagim Bakardjian
Hovagim Bakardjian
APAnh-Huy Phan
Anh-Huy Phan
YLYuanqing Li
Yuanqing Li
In addition to helping better understand how the human brain works, the brain-computer interface neuroscience paradigm allows researchers to develop a new class of bioengineering control devices and robots, offering promise for rehabilitation and other medical applications as well as exploring possibilities for advanced human-computer interfaces.

1 April 2014 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Closed access
YTYohei Tomita
Yohei Tomita
FVFrançois-Benoît Vialatte
François-Benoît Vialatte
GDGérard Dreyfus
Gérard Dreyfus
YMYasue Mitsukura
Yasue Mitsukura
HBHovagim Bakardjian
Hovagim Bakardjian
ACAndrzej Cichocki
Andrzej Cichocki
Although noninvasive brain-computer interfaces (BCI) based on electroencephalographic (EEG) signals have been studied increasingly over the recent decades, their performance is still limited in two important aspects. First, the difficulty of performing a reliable detection of BCI commands increases when EEG epoch length decreases, which makes high information transfer rates difficult to achieve. Second, the BCI system often misclassifies the EEG signals as commands, although the subject is not performing any task. In order to circumvent these limitations, the hemodynamic fluctuations in the brain during stimulation with steady-state visual evoked potentials (SSVEP) were measured using near-infrared spectroscopy (NIRS) simultaneously with EEG. BCI commands were estimated based on responses to a flickering checkerboard (ON-period). Furthermore, an “idle” command was generated from the signal recorded by the NIRS system when the checkerboard was not flickering (OFF-period). The joint use of EEG and NIRS was shown to improve the SSVEP classification. For 13 subjects, the relative improvement in error rates obtained by using the NIRS signal, for nine classes including the “idle” mode, ranged from 85% to 53 %, when the epoch length increase from 3 to 12 s. These results were obtained from only one EEG and one NIRS channel. The proposed bimodal NIRS-EEG approach, including detection of the idle mode, may make current BCI systems faster and more reliable.